Clinical evaluation of a real-time PCR assay for identification of salmonella, shigella, campylobacter (campylobacter jejuni and C. coli), and shiga toxin-producing escherichia coli isolates in stool specimens

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4001-4007

  Buchan, Blake W ^a,b   Olson, Wendy J ^a,b   Pezewski, Michael ^b   Marcon, Mario J ^c   Novicki, Thomas ^d   Uphoff, Timothy S ^d   Chandramohan, Lakshmi ^e   Revell, Paula ^e   Ledeboer, Nathan A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b DYNACARE LABORATORIES   (Canada)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d MARSHFIELD CLINIC   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FECES ANALYSIS; INTERMETHOD COMPARISON; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGELLA; STX1 GENE; STX2 GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; GASTROENTERITIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UNITED STATES; YOUNG ADULT;

EID: 84889869928     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02056-13     Document Type: Article

References (26)

1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15.
2. CDC. 2010. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food-10 states, 2009. MMWR Morb. Mortal. Wkly. Rep. 59:418-422.
3. Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P, Deneen V, Shiferaw B, Angulo FJ. 2002. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiol. Infect. 129:9-17.
4. Gordon MA. 2008. Salmonella infections in immunocompromised adults. J. Infect. 56:413-422.
5. Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, Hennessy T, Griffin PM, DuPont H, Sack RB, Tarr P, Neill M, Nachamkin I, Reller LB, Osterholm MT, Bennish ML, Pickering LK, Infectious Diseases Society of America. 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32:331-351.
6. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
7. Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, Hoekstra RM, Strockbine NA. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192:1422-1429.
8. Gould LH, Bopp C, Strockbine N, Atkinson R, Baselski V, Body B, Carey R, Crandall C, Hurd S, Kaplan R, Neill M, Shea S, Somsel P, Tobin-D'Angelo M, Griffin PM, Gerner-Smidt P, Centers for Disease Control and Prevention (CDC). 2009. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recommend. Rep. 58(RR-12):1-14.
9. Gyles CL. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 85(13 Suppl):E45-E62.
10. Karmali MA. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
11. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. 2004. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. J. Infect. Dis. 189: 556-563.
12. Kiska DL, Riddell SW. 2011. Counterpoint: should all stools be screened for Shiga toxin-producing Escherichia coli? J. Clin. Microbiol. 49:2394-2397.
13. Marcon MJ. 2011. Point: should all stools be screened for Shiga toxinproducing Escherichia coli? J. Clin. Microbiol. 49:2390-2394.
14. Vallieres E, Saint-Jean M, Rallu F. 2013. Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center. J. Clin. Microbiol. 51:481-486.
15. Coupland LJ, McElarney I, Meader E, Cowley K, Alcock L, Naunton J, Gray J. 2012. Simultaneous detection of viral and bacterial enteric pathogens using the Seeplex diarrhea ACE detection system. Epidemiol. Infect. 141:2111-2121.
16. Claas E, Burnham CA, Mazulli T, Templeton K, Topin F. 2013. Performance of the xTAG gastrointestinal pathogen panel, a multiplex molecular assay for simultaneous detection of bacterial, viral, and parasitic causes of infectious gastroenteritis. J. Microbiol. Biotechnol. 23:1041-1045.
17. Mengelle C, Mansuy JM, Prere MF, Grouteau E, Claudet I, Kamar N, Huynh A, Plat G, Benard M, Marty N, Valentin A, Berry A, Izopet J. 2013. Simultaneous detection of gastrointestinal pathogens with a multiplex Luminex-based molecular assay in stool samples from diarrhoeic patients. Clin. Microbiol. Infect. doi:10.1111/1469-0691.12255.
18. Newcombe RG. 1998. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat. Med. 17:857-872.
19. Wiström J, Jertborn M, Ekwall E, Norlin K, Söderquist B, Strömberg A, Lundholm R, Hogevik H, Lagergren L, Englund G, Norrby SR. 1992. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann. Intern. Med. 117:202-208.
20. Carlstedt G, Dahl P, Niklasson PM, Gullberg K, Banck G, Kahlmeter G. 1990. Norfloxacin treatment of salmonellosis does not shorten the carrier stage. Scand. J. Infect. Dis. 22:553-556.
21. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, Nelson JA, Mayer KW, Landau W, Parkhurst GW, Levin S. 1990. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch. Intern. Med. 150:541-546.
22. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. 2000. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342:1930-1936.
23. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181:664-670.
24. Granato PA, Chen L, Holiday I, Rawling RA, Novak-Weekley SM, Quinlan T, Musser KA. 2010. Comparison of premier CAMPY enzyme immunoassay (EIA), ProSpecT Campylobacter EIA, and ImmunoCard STAT! CAMPY tests with culture for laboratory diagnosis of Campylobacter enteric infections. J. Clin. Microbiol. 48:4022-4027.
25. Kehl KS, Havens P, Behnke CE, Acheson DW. 1997. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 35:2051-2054.
26. Johnson KE, Thorpe CM, Sears CL. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595.